MRK
Merck's first quarter 2026 revenue grew 5% on KEYTRUDA strength, prompting a raise in full-year guidance.
Merck reported first quarter 2026 sales of $16.3 billion, a 5% increase year-over-year, driven by its Oncology and Animal Health divisions. The company posted...